Vericel Corp
No enriched coverage for $VCEL in the last 7 days.
Vericel (NASDAQ: VCEL) reported Q2 earnings call updates. Burn Care revenue rose 22% to about $12M, with Epicel at $10.4M and NexoBrid above $1.5M. 2026 guidance was raised to $330M-$340M total revenue, MACI to $284M-$290M, Burn Care to $46M-$50M, and Q3 revenue to $76.5M-$78.5M. Board authorized a $200M buyback.
Vericel Corp (VCEL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991earningsreleaseq22026.htm EX-99.1 Document Exhibit 99.1 Vericel Corporation 25 Blue Sky Drive Burlington, MA 01803 T 617 588-5555 F 617 588-5554 www.vcel.com Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Sh
Flynn Sean C. (Chief Legal Officer) sold 15,000 shares of Vericel Corp (VCEL) at $45.64 ($0.68M total) on 2026-06-26 under a Rule 10b5-1 trading plan.
Recent VCEL coverage spans financial news, insider activity and earnings.
In the last 30 days, VCEL insiders filed 4 SEC Form 4 transactions — no purchases and 4 sales ($688K). The most active reporter was SIEGAL JONATHAN, Principal Accounting Officer, with 3 filings. 100% of activity was filed under pre-arranged Rule 10b5-1 plans.
Guidance raise and first buyback authorization are near-term catalysts, with margin guidance unchanged but EBITDA expansion expected to accelerate in 2027.
Raised guidance plus a new $200M buyback signals improving cash generation and supports a bullish near-term re-rating, though execution risk remains in commercial franchises.
Routine insider selling by a senior officer; likely limited incremental signal versus broader fundamentals.
Routine insider sale disclosure; signals liquidity/portfolio management more than fundamental change.
Insider selling under a 10b5-1 plan is typically low-signal for fundamentals, but it can modestly affect near-term sentiment.
alphai scores every news story that mentions VCEL with an AI model for sentiment and relevance, and aggregates insider trades from Vericel Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Vericel (NASDAQ: VCEL) reported Q2 earnings call updates. Burn Care revenue rose 22% to about $12M, with Epicel at $10.4M and NexoBrid above $1.5M. 2026 guidance was raised to $330M-$340M total revenue, MACI to $284M-$290M, Burn Care to $46M-$50M, and Q3 revenue to $76.5M-$78.5M. Board authorized a $200M buyback.
4 min readVericel Corp (VCEL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991earningsreleaseq22026.htm EX-99.1 Document Exhibit 99.1 Vericel Corporation 25 Blue Sky Drive Burlington, MA 01803 T 617 588-5555 F 617 588-5554 www.vcel.com Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Sh
6 min readFlynn Sean C. (Chief Legal Officer) sold 15,000 shares of Vericel Corp (VCEL) at $45.64 ($0.68M total) on 2026-06-26 under a Rule 10b5-1 trading plan.
1 min readFlynn Sean C. (Chief Legal Officer) sold 15,000 shares of Vericel Corp (VCEL) at $40.21 ($0.60M total) on 2026-06-18 under a Rule 10b5-1 trading plan.
2 min readHopper Jonathan Mark (Chief Medical Officer) sold 4,375 shares of Vericel Corp (VCEL) at $35.00 ($0.15M total) on 2026-06-02 under a Rule 10b5-1 trading plan.
3 min readVericel Corporation (VCEL) has amended its corporate bylaws to reflect its new global headquarters located at 25 Blue Sky Drive, Burlington, Massachusetts 01803. The amendment was approved by the Board of Directors and became effective on May 18, 2026. This change ensures that the company's official corporate records align with its updated principal executive office address.
1 min readVanguard Capital Management has disclosed a 5.11% beneficial ownership stake in Vericel (NASDAQ: VCEL), amounting to 2,603,128 shares of common stock. This is reported via a Schedule 13G SEC filing, indicating Vanguard holds these shares for investment purposes across various affiliated funds and client accounts. The filing specifies Vanguard's sole voting power over 372,372 shares and sole dispositive power over all 2,603,128 shares.
2 min readCAMBRIDGE, Mass., Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Vericel Corporation ( NASDAQ:VCEL ) , a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will participate in a fireside chat at the Stephens Annual Investment Conference at ...
3 min readCAMBRIDGE, Mass., Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Vericel Corporation ( NASDAQ:VCEL ) , a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will participate in a fireside chat at the Stephens Annual Investment Conference at ...
3 min readThe average of price targets set by Wall Street analysts indicates a potential upside of 39.4% in Vericel (VCEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
4 min read
